Lysyl oxidase (LOX), the enzymes responsible for crosslinking collagen, has been identified as upregulated in tumor-primed RDEB mice due to increased TGFβ signaling, and leading to increased ECM stiffness (Mittapalli et al, 2016). The gene discussed is LOX; the disease is neoplasm.